Global Synthesis Polypeptide Drugs Market Size, Status and Forecast 2022

January 2017 | 119 pages | ID: G0A0471F5C6EN
QYResearch

Abstracts

Notes:

Production, means the output of Synthesis Polypeptide Drugs

Revenue, means the sales value of Synthesis Polypeptide Drugs

This report studies the global Synthesis Polypeptide Drugs market, analyzes and researches the Synthesis Polypeptide Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• Novartis
• Merck Serono
• Ferring Pharmaceuticals
• Ipsen PHarma Biotech
• Lilly
• Asahi Kasei
• AstraZeneca
• SciClone Pharmaceuticals
• Takeda
• HYBIO Pharmaceutical (Shenzhen Stock:300199)
• Hainan Zhonghe Pharmaceutical

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Synthesis Polypeptide Drugs can be split into

• Immunity Regulating Medicine (Allergy Infection and Immune)
• Digestive System Drugs (Gastrointestinal Type)
• Bone and Connective Tissue Types (Thyroid hormones Drug)
• Gynecologic or Obstetric Drug
• Tumor Drug (hCG)?
• Urinary System Drug (Diabetes Insipidus)?
• Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Market segment by Application, Synthesis Polypeptide Drugs can be split into

• Application 1
• Application 2

Contents

Global Synthesis Polypeptide Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF SYNTHESIS POLYPEPTIDE DRUGS

1.1 Synthesis Polypeptide Drugs Market Overview
  1.1.1 Synthesis Polypeptide Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Synthesis Polypeptide Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Synthesis Polypeptide Drugs Market by Type
  1.3.1 Immunity Regulating Medicine (Allergy Infection and Immune)
  1.3.2 Digestive System Drugs (Gastrointestinal Type)
  1.3.3 Bone and Connective Tissue Types (Thyroid hormones Drug)
  1.3.4 Gynecologic or Obstetric Drug
  1.3.5 Tumor Drug (hCG)?
  1.3.6 Urinary System Drug (Diabetes Insipidus)?
  1.3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Synthesis Polypeptide Drugs Market by End Users/Application
  1.4.1 Application
  1.4.2 Application

2 GLOBAL SYNTHESIS POLYPEPTIDE DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Synthesis Polypeptide Drugs Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Novartis
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Merck Serono
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Ferring Pharmaceuticals
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Ipsen PHarma Biotech
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Lilly
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Asahi Kasei
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 AstraZeneca
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 SciClone Pharmaceuticals
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Takeda
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 HYBIO Pharmaceutical (Shenzhen Stock:300199)
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Synthesis Polypeptide Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Hainan Zhonghe Pharmaceutical

4 GLOBAL SYNTHESIS POLYPEPTIDE DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Synthesis Polypeptide Drugs Market Size by Type (2012-2017)
4.2 Global Synthesis Polypeptide Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Synthesis Polypeptide Drugs in Future
4.4 Top Consumer/End Users of Synthesis Polypeptide Drugs

5 UNITED STATES SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Synthesis Polypeptide Drugs Market Size (2012-2017)
5.2 United States Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

6 EU SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Synthesis Polypeptide Drugs Market Size (2012-2017)
6.2 EU Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

7 JAPAN SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Synthesis Polypeptide Drugs Market Size (2012-2017)
7.2 Japan Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

8 CHINA SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Synthesis Polypeptide Drugs Market Size (2012-2017)
8.2 China Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

9 INDIA SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Synthesis Polypeptide Drugs Market Size (2012-2017)
9.2 India Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

10 SOUTHEAST ASIA SYNTHESIS POLYPEPTIDE DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Synthesis Polypeptide Drugs Market Size (2012-2017)
10.2 Southeast Asia Synthesis Polypeptide Drugs Market Size and Market Share by Players (2015-2016)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Synthesis Polypeptide Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Synthesis Polypeptide Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Synthesis Polypeptide Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Synthesis Polypeptide Drugs Market Size by Application (2017-2022)

12 SYNTHESIS POLYPEPTIDE DRUGS MARKET DYNAMICS

12.1 Synthesis Polypeptide Drugs Market Opportunities
12.2 Synthesis Polypeptide Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Synthesis Polypeptide Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Synthesis Polypeptide Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Synthesis Polypeptide Drugs Product Scope
Figure Global Synthesis Polypeptide Drugs Market Size (2012-2017)
Table Global Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure Global Synthesis Polypeptide Drugs Market Share by Regions in 2015
Figure United States Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure EU Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure Japan Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure China Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure India Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Figure Global Synthesis Polypeptide Drugs Market Share by Type in 2015
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Market Size (Value) and Growth Rate (2012-2017)
Figure Digestive System Drugs (Gastrointestinal Type) Market Size (Value) and Growth Rate (2012-2017)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Market Size (Value) and Growth Rate (2012-2017)
Figure Gynecologic or Obstetric Drug Market Size (Value) and Growth Rate (2012-2017)
Figure Tumor Drug (hCG)? Market Size (Value) and Growth Rate (2012-2017)
Figure Urinary System Drug (Diabetes Insipidus)? Market Size (Value) and Growth Rate (2012-2017)
Figure Metabolic Drug (Insulin and Other Hypoglycemic Agents) Market Size (Value) and Growth Rate (2012-2017)
Figure Global Synthesis Polypeptide Drugs Market Share by Application in 2015
Figure Synthesis Polypeptide Drugs Market Size and Growth Rate in Applications 1 (2012-2017)
Figure Synthesis Polypeptide Drugs Market Size and Growth Rate in Applications 2 (2012-2017)
Figure Synthesis Polypeptide Drugs Market Size and Growth Rate in Applications 3 (2012-2017)
Table Synthesis Polypeptide Drugs Market Size (Value) by Players (2015-2016)
Figure Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Table Novartis Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Novartis (2012-2017)
Figure Novartis Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Merck Serono Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Merck Serono (2012-2017)
Figure Merck Serono Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Ferring Pharmaceuticals Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Ferring Pharmaceuticals (2012-2017)
Figure Ferring Pharmaceuticals Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Ipsen PHarma Biotech Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Ipsen PHarma Biotech (2012-2017)
Figure Ipsen PHarma Biotech Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Lilly Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Lilly (2012-2017)
Figure Lilly Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Asahi Kasei Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Asahi Kasei (2012-2017)
Figure Asahi Kasei Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table AstraZeneca Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of AstraZeneca (2012-2017)
Figure AstraZeneca Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table SciClone Pharmaceuticals Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of SciClone Pharmaceuticals (2012-2017)
Figure SciClone Pharmaceuticals Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Takeda Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Takeda (2012-2017)
Figure Takeda Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table HYBIO Pharmaceutical (Shenzhen Stock:300199) Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of HYBIO Pharmaceutical (Shenzhen Stock:300199) (2012-2017)
Figure HYBIO Pharmaceutical (Shenzhen Stock:300199) Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Hainan Zhonghe Pharmaceutical Basic Information List
Table Synthesis Polypeptide Drugs Business Revenue of Hainan Zhonghe Pharmaceutical (2012-2017)
Figure Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Business Revenue Market Share in 2015
Table Global Synthesis Polypeptide Drugs Market Size by Type (2012-2017)
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2011
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2012
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2013
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2014
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2015
Figure Global Synthesis Polypeptide Drugs Market Size Share by Type in 2016
Table Global Synthesis Polypeptide Drugs Market Size by Application (2012-2017)
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2011
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2012
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2013
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2014
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2015
Figure Global Synthesis Polypeptide Drugs Market Size by Application in 2016
Table Top Consumer/End Users of Synthesis Polypeptide Drugs
Figure United States Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table United States Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure United States Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure United States Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure EU Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table EU Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure EU Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure EU Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure Japan Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table Japan Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure Japan Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure Japan Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure China Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table China Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure China Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure China Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure India Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table India Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure India Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure India Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure Southeast Asia Synthesis Polypeptide Drugs Market Size and Growth Rate by Regions (2012-2017)
Table Southeast Asia Synthesis Polypeptide Drugs Market Size by Players (2012-2017)
Figure Southeast Asia Synthesis Polypeptide Drugs Market Size Share by Players in 2015
Figure Southeast Asia Synthesis Polypeptide Drugs Market Size Share by Players in 2016
Figure Global Synthesis Polypeptide Drugs Market Size (Value) by Regions (2017-2022)
Table Global Synthesis Polypeptide Drugs Market Size by Regions (2017-2022)
Figure Global Synthesis Polypeptide Drugs Market Size Share by Regions in 2017
Figure Global Synthesis Polypeptide Drugs Market Size Share by Regions in 2021